| |
| |
|
| Insider
Information: |
Rice Derica W |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
112,832 |
|
|
Indirect Shares
|
380,351 |
|
|
| Direct
Value |
$33,343,442 |
|
|
|
Indirect Value
|
$275,222,390 |
|
|
| Total
Shares |
493,183 |
|
|
| Total
Value |
$308,565,832 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
EVP-Global Services an... |
2017-02-03 |
38,292 |
2017-02-03 |
374,958 |
Premium* |
|
|
Target Corp |
TGT |
Director |
2024-03-13 |
8,159 |
2007-09-12 |
0 |
Premium* |
|
|
CVS/Caremark Corp |
CVS |
EVP & President, CVS C... |
2020-02-28 |
50,922 |
2019-05-31 |
0 |
Premium* |
|
|
Bristol-Myers Squibb Co |
BMY |
Director |
|
0 |
2020-09-01 |
1,200 |
Premium* |
|
|
The Carlyle Group Inc |
CG |
Director |
2023-05-01 |
15,459 |
2023-05-01 |
4,193 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TGT |
Target Corp |
Director |
– • – |
2024-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,873 |
8,159 |
0 |
- |
|
| CG |
The Carlyle Group Inc |
Director |
– • – |
2023-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,238 |
15,459 |
0 |
- |
|
| TGT |
Target Corp |
Director |
• • – |
2023-03-08 |
4 |
A |
$0.00 |
$0 |
D/D |
1,902 |
6,047 |
0 |
- |
|
| CG |
The Carlyle Group Inc |
Director |
– • – |
2022-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,236 |
9,221 |
0 |
- |
|
| TGT |
Target Corp |
Director |
• • – |
2022-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,432 |
4,047 |
0 |
- |
|
| CG |
The Carlyle Group Inc |
Director |
– • – |
2021-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,985 |
3,985 |
0 |
- |
|
| TGT |
Target Corp |
Director |
• • – |
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,646 |
2,583 |
0 |
- |
|
| CG |
The Carlyle Group Inc |
Director |
– • – |
2021-03-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,193 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
Director |
– • – |
2020-09-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,200 |
|
% |
|
| TGT |
Target Corp |
Director |
• • – |
2020-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
927 |
927 |
0 |
- |
|
| CVS |
CVS/Caremark Corp |
EVP & President, CVS Caremark |
• • – |
2020-02-28 |
4 |
D |
$59.18 |
$478,115 |
D/D |
(8,079) |
26,827 |
0 |
- |
|
| CVS |
CVS/Caremark Corp |
EVP & President, CVS Caremark |
• • – |
2020-02-28 |
4 |
A |
$59.18 |
$1,298,587 |
D/D |
21,943 |
34,906 |
0 |
- |
|
| CVS |
CVS/Caremark Corp |
EVP & President, CVS Caremark |
• • – |
2019-05-31 |
4 |
D |
$52.37 |
$187,275 |
D/D |
(3,576) |
12,442 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-03 |
4 |
AS |
$77.47 |
$301,513 |
D/D |
(3,892) |
38,292 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-02 |
4 |
AS |
$76.97 |
$559,572 |
D/D |
(7,270) |
42,184 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,463 |
58,443 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-02-01 |
4 |
D |
$77.03 |
$692,423 |
D/D |
(8,989) |
49,454 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2017-01-27 |
4 |
A |
$75.38 |
$2,938,312 |
D/D |
38,980 |
38,980 |
0 |
- |
|
| TGT |
Target Corp |
Director |
• • – |
2017-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
4,055 |
54,703 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-12-16 |
5 |
GD |
$0.00 |
$0 |
I/I |
400 |
365,659 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-03-21 |
5 |
GD |
$0.00 |
$0 |
I/I |
78 |
366,059 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-08 |
5 |
GD |
$0.00 |
$0 |
D/D |
36,931 |
0 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-08 |
5 |
GA |
$0.00 |
$0 |
I/I |
36,931 |
366,137 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-03 |
4 |
AS |
$76.81 |
$302,401 |
D/D |
(3,937) |
36,931 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
EVP-Global Services and CFO |
• – – |
2016-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,685 |
56,560 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
